2022年第14期
共19篇·Consensus Statement
1. Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy 1639-1641页
作者:Mei HengChen FangpingHan YueHou MingHuang HeHuang XiaojunLi YuhuaLiang AibinLiu QifaNiu TingPeng JunQian WenbinSong YongpingWang JianxiangWang YingWu DepeiXu KailinYang LinhuaYang RenchiZhang LeiZhang LianshengZhang XiZhang XiaohuiZhao WeiliHan WeidongHu Yu
·Review Article
2. Intestinal homeostasis in autoimmune liver diseases 1642-1652页
3. Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease 1653-1663页
作者:Tong XinSong YuYin ShengxiaWang JianHuang RuiWu ChaoShi JunpingLi Jie
5. Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease 1673-1681页
·Meta Analysis
6. Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis 1682-1691页
作者:Liu JiayeTian YeFu XiaMu ChunyangYao MenglinNi YinyunLiu YongLi Zhihui
·Perspective
·Commentary
8. Comments on "Anatomically distinct fibroblast subsets determine skin autoimmune patterns" 1695-1696页
·Original Article
9. Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019 1697-1706页
作者:Chen ShiminHan KeSong YangLiu ShaohuaLi XuehangWang ShengshuLi HaoweiLi RongrongWang JianhuaHe YaoLiu Miao
10. Efficacy and safety of high-dose esomeprazole–amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial 1707-1715页
作者:Bi HanxinChen XingxingChen YuxinZhao XinWang ShashaWang JiehongLyu TingHan ShuangLin TaoLi MingquanYuan DonghongLiu JunyeShi Yongquan
11. Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity 1716-1727页
作者:Liu ZuojingZhu ShiweiHe MeiboLi MoWei HuiZhang LuSun QinghuaJia QiongHu NanFang YuanSong LijinZhou ChenTao HeqingY Kao JohnZhu HuaiqiuOwyang ChungDuan Liping
12. Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma 1728-1733页
13. Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han population 1734-1741页
作者:Mo HongnanMa FeiLi QingZhang PinYuan PengWang JiayuLuo YangCai RuigangLi QiaoXu Binghe
14. National incidence of joint dislocation in China: a retrospective survey of 512,187 individuals 1742-1749页
作者:Lv HongzhiChen WeiHou ZhiyongJia SimingZhu YanbinLiu BoChen XiaoYang GuangLiu LeiZhang TaoWang HailiYin BingLiu SongGuo JialiangZhang XiaolinLi YichongZhang Yingze
·Clinical Observation
15. Effect of laparoscopic angle of His reconstruction in the treatment of patients with gastroesophageal reflux disease and hiatal hernia 1750-1752页
作者:Zhang RuiLi ZhitongLi ChunxiaJi FengHan XinweiWang Zhonggao
16. Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) 1753-1755页
作者:Qu FengjiangWu DiLiu YunjiangGao WeiWang ShuWang SiyuanJin FengChen BoHuang JianSun ShanshanFan ZhiminChinese Society of Breast Surgery
·Correspondence
17. Clinical and immunological characteristics of vaccinated patients with COVID-19 1756-1758页
作者:Ping YuHuang JianminFan FeifeiGuo YongjunGou JianjunZhang Yi